K Health: $1.4B valuation, IPO Readiness 70, Series H. AI-powered primary care platform providing personalized healthcare via data-driven clinical decisions. Track live on The IPO Stack.
AI-powered primary care platform providing personalized healthcare via data-driven clinical decisions.
Scores, valuations, and IPO signals for the companies that matter. 5-minute read, every Tuesday.
Top companies most likely to IPO in 2026, ranked by IPO Readiness Score.
Track K Health IPO timeline, funding rounds, investor activity, and valuation on TechStackIPO — the pre-IPO intelligence platform.
K Health has not announced a specific IPO date as of 2026. With an IPO Readiness Score of 70/100, the company shows strong pre-IPO signals. Subscribe to The IPO Stack newsletter for weekly updates.
K Health is valued at $1.4B as of July 2021. This valuation is based on its most recent private funding round tracked by TechStackIPO.
Accredited investors can access K Health shares through secondary market platforms, pre-IPO investment funds, and broker-dealer platforms that facilitate private company transactions. TechStackIPO's marketplace tracks available access options. Note: pre-IPO investments carry higher risk and limited liquidity compared to public market investing.
K Health scores 70/100 (Grade: B) on TechStackIPO's IPO Readiness Index. The score evaluates funding scale, valuation trajectory, funding momentum, stage progression, and company maturity. Scores above 70 indicate strong near-term IPO potential.
K Health has raised $481M in total venture capital and private equity funding, with backing from Meritech Capital, GGV Capital, Anthem.
K Health's notable investors include Meritech Capital, GGV Capital, Anthem, Valor Equity Partners, Max Ventures. Full investor details, funding round history, and lead investor breakdowns are available on TechStackIPO.
K Health is a Healthcare Technology company. AI-powered primary care platform providing personalized healthcare via data-driven clinical decisions.